The EPS projection of Humana Inc. (NYSE:HUM) for quarter ended 2016-09-30 is $2.79. A week before, the EPS forecast was $2.79 against target of $2.79, a month earlier. This estimate stood at $2.79 60 days earlier versus forecast of $2.79 90 days earlier, confirming a deviation of 0%.
Humana Inc. (NYSE:HUM) reported that 18 days ago, the positive EPS revisions were 8 and negative revisions at 0.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 5, 5, 1 and 5, respectively.
The downgrade of EPS estimates for Humana Inc. (NYSE:HUM) in the preceding 120, 60, 30 and 90 days were 4, 4, 0 and 4, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of Humana Inc. (NYSE:HUM) was $2.79. This projection was computed after accounting 12 calls. As reported on 2016-05-04 the EPS was $1.86. The change was $0.05, demonstrating a percentage deviation of 2.76%. The projections confirmed a standard deviation of 0.02.
Quarterly Sales Estimates
For the fiscal 2017, the yearly sales target for Humana Inc. (NYSE:HUM) stands at $14222.102 and the median estimate at $14053.22. Almost 5 analysts announced their estimates.
The highest estimate is $14919 while the lowest target is $13544.6 showing standard deviation of 549.076%.
As many as 5 analysts released sales estimates reised in upside while 5 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 5 revised sales number projection on upside while 5 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 5 hiked sales estimations and 5 reduced sales forecast. Humana Inc. (NYSE:HUM) stated that the change in forecast was -0.387%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...